IBIO on the WHO’s list for the trial candidates(EBOLA)> Mapp Biopharmaceuticals’ experimental Ebola drug ZMapp is perhaps the most advanced drug to date, and is also on the WHO’s list for the trial candidates. However, supplies of the drug have been exhausted. The company is currently looking for different ways to increase production, one of which is collaboration with Caliber Biotherapeutics and Ibio Inc (IBIO) http://www.bidnessetc.com/27717-tekmira-gains-on-new-ebola-drug-update/2/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.